Entity family
Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.
Showing 4,141–4,200 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
…ve lesions or discontinuation of FLST followed by initiation of SLST. RT will be delivered with a biologically effective dose (linea…
…pNo*Usual care groupDifference (95% CI)Median (IQR) duration of antibiotic treatment (days) Blood culture positive sepsis (intention-to-treat)1579.0…
…of the 19 patient oriented interventions. Structured reviews of drug treatment use featured in eight of the 10 organisational interventions, b…
…nts with LVO were finally included in this analysis. After PSM, EVT was associated with increased odds of improved shift pediatric …
…of the disease characteristics that had warranted initiation of csDMARDs, we used Directed Acyclic Graphs to construct a causal model fo…
… in both early-stage and metastatic settings when combined with chemotherapy. Poly (ADP-ribose) polymerase (PARP) inhibitors, particularly o…
…2%) treated with I125 brachytherapy and 63 (20.3%) treated with PBR. Local tumour control was achieved in 95.8% of cases. The recur…
…6.6%) and bowel (AOR 1.38; 47.5% vs 35.4%) disorders.Conclusion Cholecystectomy is prevalent worldwide and varies across world regions. A histo…
…DAPT resulted in numerically more favorable functional outcome. PCA resulted in numerically higher numbers of symptomatic intracran…
…3 received placebo, 403 received no treatment and 5735 received chemotherapy), while 10 076 patients were treated with ICI monotherapy.These…
…ts with refractory intracranial atherosclerotic disease (ICAD), percutaneous transluminal balloon angioplasty (PTBA) is less complex but typically results in higher postproc…
…removed anal tumours with margins ≤1 mm will receive lower dose chemoradiotherapy, while participants with anal tumours with margins >1 mm will b…